Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup
Vivek Venkatramani(University of Miami), Dipen J. Parekh(University of Miami), Ahmad Shabsigh(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Ian M. Thompson(The University of Texas at San Antonio Health Science Center), Robert S. Svatek(The University of Texas at San Antonio Health Science Center), Alon Z. Weizer(University of Michigan), Edward Uchio(University of California, Irvine), Kerri Kendrick(The University of Texas at San Antonio Health Science Center), Alex Gorbonos(Loyola University Medical Center), Tracey L. Krupski(University of Virginia Cancer Center), Michael S. Cookson(University of Oklahoma Health Sciences Center), Marcus L. Quek(Loyola University Medical Center), Mathew Tollefson(WinnMed), Isildinha M. Reis(University of Miami), Badrinath R. Konety(Allina Health), Daniel A. Barocas(Vanderbilt University Medical Center), Gopal N. Gupta(Loyola University Medical Center), Michael Woods(University of Cambridge), Adam S. Kibel(Brigham and Women's Hospital), Raj S. Pruthi(University of North Carolina at Chapel Hill), Nachiketh Soodana‐Prakash(University of Miami), Christopher Weight, Joseph A. Smith(King's College London), Sam S. Chang(Vanderbilt University), David S. Sharp(The Ohio State University), Atreya Dash(University of Washington), Eila C. Skinner(Stanford University), Sanjaya Swain(University of Miami), Norm D. Smith(Caris Life Sciences (United States)), Jeffrey S. Montgomery(Ann Arbor Center for Independent Living), Mark L. Gonzalgo(University of Miami), Maria F. Becerra(Memorial Sloan Kettering Cancer Center), Erik P. Castle(WinnMed)
Cited by 116
Related Papers
The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia
|New England Journal of Medicine|2003|2k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k